Implantation rates in unstimulated IVF cycles compared favorably with those in stimulated IVF cycles in a retrospective analysis.
For couples who have difficulty conceiving, natural cycle in vitro fertilization (IVF) is a good alternative option for a wide range of patients, concluded the authors of a retrospective analysis.1
According to data reported to the Society of Assisted Reproductive Technology (SART) in 2006 and 2007, unstimulated IVF, also called natural cycle IVF, accounted for less than 1% of all IVF cycles initiated in the United States. Unstimulated IVF differs from standard, or stimulated, IVF in that unstimulated IVF does not involve the use of ovary-stimulating medications. Instead, the growth of the dominant follicle is tracked with ultrasounds and blood tests, and the egg is retrieved when the dominant follicle is deemed large enough. As with traditional IVF, the retrieved egg is then fertilized and, if an embryo is produced and continues to develop, it is transferred back to the uterus.
Unstimulated IVF is associated with less risk than traditional IVF because fewer medications are needed; thus, the risk of ovarian hyperstimulation syndrome (OHSS) is eliminated. Also, unstimulated IVF is less costly, requires fewer office visits, and results in less physical and emotional stress.2
According to SART data, a total of 795 cases of unstimulated IVF cycles were initiated in 2006 and 2007.1 The investigators reported that the success rates of unstimulated IVF were largely dependent on age. In patients younger than 35 years, the clinical pregnancy rates per cycle, retrieval, and transfer were 19.2%, 26.8%, and 35.9%, respectively. For this age group, the pregnancy rate was 19.2% and the live birth rate was 15.2% per initiated cycle.
In patients aged 35 to 42 years, the investigators found that implantation rates were statistically higher for unstimulated IVF compared with stimulated IVF. Overall, implantation rates in unstimulated IVF cycles compared favorably with those in stimulated IVF cycles, the investigators concluded.
It has been reported that unstimulated IVF is a reasonable option not only for infertile couples undergoing their initial cycle of IVF but also for women considered “poor responders” to continue the IVF process even after ovarian stimulation has repeatedly failed to produce multiple embryos.2
Pertinent Points:
- Implantation rates in unstimulated IVF cycles favorably compare to stimulated IVF.
- Natural cycle IVF may be a good alternative treatment option for infertile couples.
- Unstimulated IVF accounts for less than 1% of all IVF cycles in the United States.
1. Gordon JD, Dimattina M, Reh A, et al. Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database. Fertil Steril. 2013 Apr 13. doi: 10.1016/j.fertnstert.2013.03.037. [Epub ahead of print.]
2. Bendikson K. Natural cycle IVF: today and tomorrow. April 14, 2010. Available at: http://uscfertility.org/blog/post/213-natural-cycle-ivf-today-and-tomorrow. Accessed July 31, 2013.
Cesarean deliveries linked to reduced fecundability and increased infertility risk
June 27th 2024A recent study found that women with multiple children and a history of cesarean deliveries face lower fecundability and higher infertility risks compared to those with vaginal deliveries.
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More